Geode Capital Management
ENZ

Geode Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Geode Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-431,042
Closed -$160K – 4563
2025
Q1 		$160K Buy
431,042
+63,949
+17% +$35.3K ﹤0.01% 3909
2024
Q4 		$262K Sell
367,093
-1,553
-0.4% -$1.61K ﹤0.01% 3812
2024
Q3 		$413K Buy
368,646
+11,742
+3% +$13.1K ﹤0.01% 3667
2024
Q2 		$389K Buy
356,904
+19,048
+6% +$21.5K ﹤0.01% 3663
2024
Q1 		$429K Hold
337,856
– – ﹤0.01% 3671
2023
Q4 		$470K Hold
337,856
– – ﹤0.01% 3641
2023
Q3 		$473K Buy
337,856
+281
+0.1% +$424 ﹤0.01% 3621
2023
Q2 		$621K Sell
337,575
-17,467
-5% -$40.4K ﹤0.01% 3561
2023
Q1 		$863K Buy
355,042
+2,194
+0.6% +$3.26K ﹤0.01% 3410
2022
Q4 		$504K Sell
352,848
-4,696
-1% -$9.15K ﹤0.01% 3654
2022
Q3 		$797K Buy
357,544
+977
+0.3% +$2.36K ﹤0.01% 3508
2022
Q2 		$738K Buy
356,567
+6,746
+2% +$16.7K ﹤0.01% 3555
2022
Q1 		$1.01M Buy
349,821
+3,336
+1% +$10.7K ﹤0.01% 3615
2021
Q4 		$1.11M Hold
346,485
– – ﹤0.01% 3669
2021
Q3 		$1.23M Sell
346,485
-2,736
-0.8% -$9.13K ﹤0.01% 3579
2021
Q2 		$1.11M Sell
349,221
-310,804
-47% -$978K ﹤0.01% 3539
2021
Q1 		$2.27M Buy
660,025
+60,829
+10% +$189K ﹤0.01% 3201
2020
Q4 		$1.51M Buy
599,196
+11,714
+2% +$25.5K ﹤0.01% 3218
2020
Q3 		$1.24M Buy
587,482
+12,477
+2% +$29.6K ﹤0.01% 3122
2020
Q2 		$1.29M Buy
575,005
+15,262
+3% +$39.2K ﹤0.01% 3062
2020
Q1 		$1.42M Buy
559,743
+45,951
+9% +$113K ﹤0.01% 2857
2019
Q4 		$1.35M Buy
513,792
+2,927
+0.6% +$8.74K ﹤0.01% 3164
2019
Q3 		$1.84M Buy
510,865
+28,684
+6% +$102K ﹤0.01% 2989
2019
Q2 		$1.62M Buy
482,181
+56,875
+13% +$200K ﹤0.01% 3064
2019
Q1 		$1.16M Buy
425,306
+14,168
+3% +$46.4K ﹤0.01% 3104
2018
Q4 		$1.14M Sell
411,138
-61,681
-13% -$202K ﹤0.01% 3047
2018
Q3 		$1.95M Buy
472,819
+17,636
+4% +$80.1K ﹤0.01% 2896
2018
Q2 		$2.36M Buy
455,183
+54,245
+14% +$331K ﹤0.01% 2760
2018
Q1 		$2.2M Buy
400,938
+65,118
+19% +$459K ﹤0.01% 2708
2017
Q4 		$2.74M Buy
335,820
+3,685
+1% +$35.2K ﹤0.01% 2582
2017
Q3 		$3.48M Sell
332,135
-1,167
-0.4% -$13K ﹤0.01% 2419
2017
Q2 		$3.68M Buy
333,302
+42,183
+14% +$393K ﹤0.01% 2360
2017
Q1 		$2.44M Buy
291,119
+23,036
+9% +$162K ﹤0.01% 2546
2016
Q4 		$1.86M Buy
268,083
+6,965
+3% +$44.5K ﹤0.01% 2669
2016
Q3 		$1.33M Sell
261,118
-28,868
-10% -$172K ﹤0.01% 2792
2016
Q2 		$1.73M Buy
289,986
+109,141
+60% +$606K ﹤0.01% 2565
2016
Q1 		$822 Buy
180,845
+5,309
+3% +$23.6K ﹤0.01% 2989
2015
Q4 		$789K Hold
175,536
– – ﹤0.01% 3037
2015
Q3 		$556K Buy
175,536
+17,715
+11% +$53.7K ﹤0.01% 3175
2015
Q2 		$478K Sell
157,821
-28,782
-15% -$80.9K ﹤0.01% 3225
2015
Q1 		$550K Buy
186,603
+7,250
+4% +$23.7K ﹤0.01% 3156
2014
Q4 		$795K Buy
179,353
+3,790
+2% +$18.1K ﹤0.01% 2971
2014
Q3 		$903K Buy
175,563
+1,829
+1% +$9.76K ﹤0.01% 2834
2014
Q2 		$912K Buy
173,734
+24,484
+16% +$106K ﹤0.01% 2855
2014
Q1 		$620K Buy
149,250
+62,622
+72% +$215K ﹤0.01% 3053
2013
Q4 		$252K Hold
86,628
– – ﹤0.01% 3351
2013
Q3 		$218K Hold
86,628
– – ﹤0.01% 3279
2013
Q2 		$180K Buy
+86,628
New +$191K ﹤0.01% 3267

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Geode Capital Management's ENZ Position: Q2 2025 in Review

Geode Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 431,042 shares — an estimated $160K sold.

Geode Capital Management first reported a position in ENZ in Q2 2013 and held it in 48 quarters. The position peaked at $3.68M in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Geode Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 431,042 Enzo Biochem, Inc. shares in Q2 2025, an estimated $160K.
  • Geode Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 48 quarters.
  • Geode Capital Management's Enzo Biochem, Inc. position peaked at $3.68M in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.